Myocardial Salvaging Effects of Berberine in Experimental Diabetes Co-Existing with Myocardial Infarction.

about

Myocardial Salvaging Effects of Berberine in Experimental Diabetes Co-Existing with Myocardial Infarction.

Item

http://www.wikidata.org/entity/Q40571635

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Myocardial Salvaging Effects o ...... ng with Myocardial Infarction.

@en

type

Item

label

Myocardial Salvaging Effects o ...... ng with Myocardial Infarction.

@en

prefLabel

Myocardial Salvaging Effects o ...... ng with Myocardial Infarction.

@en

P1476

Myocardial Salvaging Effects o ...... ng with Myocardial Infarction.

@en

P2093

Ipseeta Ray Mohanty

http://www.w3.org/2001/XMLSchema#string

Manjusha K Borde

http://www.w3.org/2001/XMLSchema#string

Rajesh Kumar Suman

http://www.w3.org/2001/XMLSchema#string

Ujwala Maheshwari

http://www.w3.org/2001/XMLSchema#string

Y A Deshmukh

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine

Free fatty acids and insulin resistance

Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials

Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion

Cardiac function in mice lacking the glucagon-like peptide-1 receptor

Cardiovascular and metabolic effects of Berberine.

Protective Effects of Berberine on Isoproterenol-Induced Acute Myocardial Ischemia in Rats through Regulating HMGB1-TLR4 Axis.

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.

Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance.

P304

FF13-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7860/JCDR/2016/15794.7459

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27134894

http://www.w3.org/2001/XMLSchema#string

P932

4843280

http://www.w3.org/2001/XMLSchema#string